JPMorgan Chase (Preferred)
Why Robinhood?
You can watch JPM-H and buy or sell other stocks, ETFs, and their options commission-free!About JPM-H
JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.
JPM-H Key Statistics
JPM-H News
Exclusive JPMorgan Chase CEO Jamie Dimon Sees an End on the Horizon. But Not Yet....
JPMorgan Chase (NYSE:JPM) has launched a new athlete-focused wealth management and financial literacy initiative. The program includes the formation of an Athl...
In trading on Thursday, shares of JPMorgan Chase & Co's 4.55% Dep Shares Non-Cumulative Preferred Stock Series JJ (Symbol: JPM.PRK) were yielding above the 6% m...
More JPM-H News
Wall Street has turned on private credit. Leading banks Goldman Sachs (GS) and JPMorgan Chase (JPM) are now offering their hedge fund clients new ways to bet a...
Complacent investors who assume there will be a swift resolution to the Iran war are making a high-risk bet given how bad surging oil prices typically end up be...
JPMorgan Chase (JPM) formed a nine-member Athlete Council to provide advice to JPMorgan leaders on the financial needs of athletes, the company said on Wednesda...
JPMorgan Chase (JPM) is calling on football legend Tom Brady to help launch its new athlete wealth management unit. Claim 70% Off TipRanks Premium Unlock hedge...
Markets Bank Stocks Are the Canary in the Recession Coal Mine. It’s Not Time to Worry—Yet In this article JPM BAC Bank stocks including JPMorgan and Bank of Ame...
For investors wondering whether JPMorgan Chase at around US$286.89 is still offering value or if most of the opportunity is already priced in, this article expl...
A significant price target boost from an analyst at a prominent U.S. bank was the main catalyst behind Edgewise Therapeutics' (EWTX +2.18%) rise on the stock ma...
